Effects of ibuprofen treatment on the developing preterm baboon kidney

American Journal of Physiology - Renal Physiology

Volumn 302, Issue 10, 2012, Pages

  Sutherland, Megan R ^a   Yoder, Bradley A ^b   McCurnin, Donald ^c   Seidner, Steven ^c   Gubhaju, Lina ^a   Clyman, Ronald I ^d   Jane Black, M ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Nephrogenesis; NSAID; Patent ductus arteriosus

Indexed keywords

IBUPROFEN; N(G) METHYLARGININE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BABOON; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; GESTATION PERIOD; HUMAN; INFANT; KIDNEY DEVELOPMENT; KIDNEY MASS; MORPHOLOGY; NEPHRON; NONHUMAN; PREMATURITY; PRIORITY JOURNAL;

EID: 84861111155     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00216.2011     Document Type: Article

References (36)

1. Allegaert K. The impact of ibuprofen or indomethacin on renal drug clearance in neonates. J Matern Fetal Neonatal Med 22, Suppl 3: 88-91, 2009.
2. Clyman RI, Waleh N, Black SM, Riemer RK, Mauray F, Chen YQ. Regulation of ductus arteriosus patency by nitric oxide in fetal lambs: the role of gestation, oxygen tension, and vasa vasorum. Pediatr Res 43: 633-644, 1998.
3. Coceani F, Kelsey L, Seidlitz E. Occurrence of endothelium-derived relaxing factor-nitric oxide in the lamb ductus arteriosus. Can J Physiol Pharmacol 72: 82-88, 1994.
4. Cuzzolin L, Fanos V, Pinna B, di Marzio M, Perin M, Tramontozzi P, Tonetto P, Cataldi L. Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions. Pediatr Nephrol 21: 931-938, 2006.
5. dos Santos AM, Fonseca Ferraz ML, Pinto Rodriguez ML, Dos Reis MA, Miranda Correa RR, de Paula Antunes Teixeira V, da Cunha Castro EC. Assessment of renal maturity by assisted morphometry in autopsied fetuses. Early Hum Dev 82: 709-713, 2006.
6. Faa G, Gerosa C, Fanni D, Nemolato S, Locci A, Cabras T, Marinelli V, Puddu M, Zaffanello M, Monga G, Fanos V. Marked interindividual variability in renal maturation of preterm infants: lessons from autopsy. J Matern Fetal Neonatal Med 23, Suppl 3: 129-133, 2010.
7. Garg UC, Hassid A. Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators. Am J Physiol Renal Fluid Electrolyte Physiol 257: F60-F66, 1989.
8. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 102: 895-906, 1983.
9. Gubhaju L, Sutherland MR, Black MJ. Preterm birth and the kidney: implications for long-term renal health. Reprod Sci 18: 322-333, 2011.
10. Gubhaju L, Sutherland MR, Yoder BA, Zulli A, Bertram JF, Black MJ. Is nephrogenesis affected by preterm birth? Studies in a nonhuman primate model. Am J Physiol Renal Physiol 297: F1668-F1677, 2009.
11. Hermes-DeSantis ER, Clyman RI. Patent ductus arteriosus: pathophysiology and management. J Perinatol 26, Suppl 1: S14-S18, 2006.
12. Hinchliffe SA, Sargent PH, Chan YF, van Velzen D, Howard CV, Hutton JL, Rushton DI. "Medullary ray glomerular counting" as a method of assessment of human nephrogenesis. Pathol Res Pract 188: 775-782, 1992.
13. Hinchliffe SA, Sargent PH, Howard CV, Chan YF, van Velzen D. Human intrauterine renal growth expressed in absolute number of glomeruli assessed by the disector method and Cavalieri principle. Lab Invest 64: 777-784, 1991.
14. Kang NS, Yoo KH, Cheon H, Choi BM, Hong YS, Lee JW, Kim SK. Indomethacin treatment decreases renal blood flow velocity in human neonates. Biol Neonate 76: 261-265, 1999.
15. Kaplan BS, Restaino I, Raval DS, Gottlieb RP, Bernstein J. Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents. Pediatr Nephrol 8: 700-704, 1994.
16. Keller RL, Tacy TA, Fields S, Ofenstein JP, Aranda JV, Clyman RI. Combined treatment with a nonselective nitric oxide synthase inhibitor (L-NMMA) and indomethacin increases ductus constriction in extremely premature newborns. Pediatr Res 58: 1216-1221, 2005.
17. Kent AL, Douglas-Denton R, Shadbolt B, Dahlstrom JE, Maxwell LE, Koina ME, Falk MC, Willenborg D, Bertram JF. Indomethacin, ibuprofen and gentamicin administered during late stages of glomerulogenesis do not reduce glomerular number at 14 days of age in the neonatal rat. Pediatr Nephrol 24: 1143-1149, 2009.
18. Kent AL, Maxwell LE, Koina ME, Falk MC, Willenborg D, Dahlstrom JE. Renal glomeruli and tubular injury following indomethacin, ibuprofen, and gentamicin exposure in a neonatal rat model. Pediatr Res 62: 307-312, 2007.
19. Komhoff M, Wang JL, Cheng HF, Langenbach R, McKanna JA, Harris RC, Breyer MD. Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development. Kidney Int 57: 414-422, 2000.
20. Muhl H, Sandau K, Brune B, Briner VA, Pfeilschifter J. Nitric oxide donors induce apoptosis in glomerular mesangial cells, epithelial cells and endothelial cells. Eur J Pharmacol 317: 137-149, 1996.
21. Norwood VF, Morham SG, Smithies O. Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice. Kidney Int 58: 2291-2300, 2000.
22. Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 4: CD003481, 2010.
23. Olliges A, Wimmer S, Nusing RM. Defects in mouse nephrogenesis induced by selective and non-selective cyclooxygenase-2 inhibitors. Br J Pharmacol 2011.
24. Rodriguez MM, Gomez AH, Abitbol CL, Chandar JJ, Duara S, Zilleruelo GE. Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants. Pediatr Dev Pathol 7: 17-25, 2004.
25. Saez F, Reverte V, Salazar F, Castells MT, Llinas MT, Salazar FJ. Hypertension and sex differences in the age-related renal changes when cyclooxygenase-2 activity is reduced during nephrogenesis. Hypertension 53: 331-337, 2009.
26. Seidner SR, Chen YQ, Oprysko PR, Mauray F, Tse MM, Lin E, Koch C, Clyman RI. Combined prostaglandin and nitric oxide inhibition produces anatomic remodeling and closure of the ductus arteriosus in the premature newborn baboon. Pediatr Res 50: 365-373, 2001.
27. Sener A, Smith FG. Glomerular and tubular responses to NG-nitro-Larginine methyl ester are age dependent in conscious lambs. Am J Physiol Regul Integr Comp Physiol 282: R1512-R1520, 2002.
28. Siassi B, Blanco C, Cabal LA, Coran AG. Incidence and clinical features of patent ductus arteriosus in low-birthweight infants: a prospective analysis of 150 consecutively born infants. Pediatrics 57: 347-351, 1976.
29. Sodini D, Baragatti B, Barogi S, Laubach VE, Coceani F. Indomethacin promotes nitric oxide function in the ductus arteriosus in the mouse. Br J Pharmacol 153: 1631-1640, 2008.
30. Speziale MV, Allen RG, Henderson CR, Barrington KJ, Finer NN. Effects of ibuprofen and indomethacin on the regional circulation in newborn piglets. Biol Neonate 76: 242-252, 1999.
31. Sutherland MR, Gubhaju L, Moore L, Kent AL, Dahlstrom JE, Horne RS, Hoy WE, Bertram JF, Black MJ. Accelerated maturation and abnormal morphology in the preterm neonatal kidney. J Am Soc Nephrol 22: 1365-1374, 2011.
32. Sutherland MR, Gubhaju L, Yoder BA, Stahlman MT, Black MJ. The effects of postnatal retinoic acid administration on nephron endowment in the preterm baboon kidney. Pediatr Res 65: 397-402, 2009.
33. van der Heijden BJ, Carlus C, Narcy F, Bavoux F, Delezoide AL, Gubler MC. Persistent anuria, neonatal death, and renal microcystic lesions after prenatal exposure to indomethacin. Am J Obstet Gynecol 171: 617-623, 1994.
34. Vassalle C, Domenici C, Lubrano V, L'Abbate A. Interaction between nitric oxide and cyclooxygenase pathways in endothelial cells. J Vasc Res 40: 491-499, 2003.
35. Waleh N, Seidner S, McCurnin D, Yoder B, Liu BM, Roman C, Mauray F, Clyman RI. The role of monocyte-derived cells and inflammation in baboon ductus arteriosus remodeling. Pediatr Res 57: 254-262, 2005.
36. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 96: 7563-7568, 1999.